Atherosclerosis

Journal

Publication Venue For

  • Pregnancy-related events associated with subclinical cardiovascular disease burden in late midlife: SWAN.  289:27-35. 2019
  • The association of midlife cardiorespiratory fitness with later life carotid atherosclerosis: Cooper Center Longitudinal Study.  282:137-142. 2019
  • Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.  277:186-194. 2018
  • Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.  244:93-100. 2016
  • The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification.  243:357-363. 2015
  • Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.  243:192-197. 2015
  • Oxidative stress, inflammation, and markers of cardiovascular health.  243:38-43. 2015
  • Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients.  242:87-96. 2015
  • Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials.  241:433-442. 2015
  • Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The coronary artery risk development in young adults study.  235:599-605. 2014
  • Damage of the endothelial glycocalyx in chronic kidney disease.  234:335-343. 2014
  • Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: A prospective study.  236. 2014
  • RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).  233:666-672. 2014
  • Contribution of arginase activation to vascular dysfunction in cigarette smoking.  231:91-94. 2013
  • Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.  228:124-135. 2013
  • Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.  227:58-64. 2013
  • Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.  224:326-331. 2012
  • Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: Differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.  221:66-75. 2012
  • Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.  216:217-225. 2011
  • OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.  214:279-287. 2011
  • Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.  213:449-457. 2010
  • Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.  209:381-386. 2010
  • Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2.  208:134-141. 2010
  • Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice.  208:90-96. 2010
  • LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.  204:171-177. 2009
  • Smoking, inflammatory patterns and postprandial hypertriglyceridemia.  203:633-639. 2009
  • Tooth loss, systemic inflammation, and prevalent stroke among participants in the reasons for geographic and racial difference in stroke (REGARDS) study.  203:615-619. 2009
  • IL1B genetic variation and plasma C-reactive protein level among young adults: The CARDIA study.  202:513-520. 2009
  • Adiponectin reduces lipid accumulation in macrophage foam cells.  202:152-161. 2009
  • Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-κB activation in vascular smooth muscle cells.  201:248-257. 2008
  • Impaired endothelial function in C-reactive protein overexpressing mice.  201:318-325. 2008
  • Neointimal formation is reduced after arterial injury in human crp transgenic mice.  201:85-91. 2008
  • Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.  200:345-349. 2008
  • Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: The NHLBI Family Heart Study follow-up examination.  199:172-178. 2008
  • A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease.  198:136-144. 2008
  • Evidence of QTL on 15q21 for high-density lipoprotein cholesterol: The National Heart, Lung, and Blood Institute Family Heart Study (NHLBI FHS).  190:232-237. 2007
  • Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.  188:292-300. 2006
  • Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.  188:102-111. 2006
  • Hyperhomocysteinemia due to Helicobacter pylori? [5].  172:199-200. 2004
  • Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.  168:229-237. 2003
  • Site-specific progression of carotid artery intimal-medial thickness.  171:137-143. 2003
  • The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.  165:259-269. 2002
  • pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque.  164:27-35. 2002
  • Atherosclerotic plaque-like lesions in synthetic arteriovenous grafts: Implications for atherogenesis.  160:133-139. 2002
  • Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: The NHLBI family heart study.  154:747-754. 2001
  • The distribution of oxidatively-modified lysine in the human vasculature.  148:255-263. 2000
  • Smoking and atherosclerosis in youth.  144:403-408. 1999
  • Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: The atherosclerosis risk in communities and the NHLBI family heart studies.  138:111-116. 1998
  • Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136 → Ser) variant in multigenerational pedigree studies.  122:33-46. 1996
  • The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.  119:169-179. 1996
  • Effect of age, race, body surface area, heart weight and atherosclerosis on coronary artery dimensions in young males.  123:243-250. 1996
  • Characterization of plasma lipids and lipoproteins in patients with β2-glycoprotein I (apolipoprotein H) deficiency.  55:25-34. 1985
  • International Standard Serial Number (issn)

  • 0021-9150
  • Electronic International Standard Serial Number (eissn)

  • 1879-1484